The antitumor drug fostriecin induces vimentin hyperphosphorylation and intermediate filament reorganization

Carcinogenesis

Volumn 17, Issue 5, 1996, Pages 967-972

  Ho, Duncan T ^a   Roberge, Michel ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN DEPENDENT KINASE; FOSTRIECIN; PROTEIN KINASE C; STAUROSPORINE; VIMENTIN;

ANIMAL CELL; ARTICLE; CELL SHAPE; CELL STRAIN BHK; CONTROLLED STUDY; DRUG MECHANISM; INTERMEDIATE FILAMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ALKALOIDS; ALKENES; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CDC2 PROTEIN KINASE; CELLS, CULTURED; CRICETINAE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; INTERMEDIATE FILAMENTS; MOLECULAR WEIGHT; PHOSPHORYLATION; PROTEIN KINASE C; PYRONES; STAUROSPORINE; VIMENTIN;

EID: 0029971096     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.5.967     Document Type: Article

References (36)

1. Jackson,R.C., Fry,D.W., Boritzki,T.J., Roberts,B.J., Hook,K.E. and Leopold,W.R. (1985) The biochemical pharmacology of CI-920, a structurally novel antibiotic with antileukemic activity. Adv. Enzyme Regul., 23, 193-215.
2. Schilsky,R.L., Ramirez,J., Wilson,K., Vokes,E., Kobayashi,K., Berezin,F., Wulff,W. and Ratain,M.J. (1994) Proc. Annu. Meet. Am. Soc. Clin. Oncol., vol. 13, p. A321.
3. Moore,M.J., Erlichman,C., Pillon,L., Manzo,J., Thiessen,J.J. and Eisenhauer,E. (1995) A phase I study of fostriecin in a daily X 5 schedule. Proc. Annu. Meet. Am. Assoc. Cancer Res., vol. 36, p. 239.
4. Boritzki,T.J., Wolfard,T.S., Besserer,J.A., Jackson,R.C. and Fry,D.W. (1988) Inhibition of type II topoisomerase by fostriecin. Biochem. Pharmacol., 37, 4063-4068.
5. Frosina,G. and Rossi,O. (1992) Effect of topoisomerase poisoning by antitumor drugs VM 26, fostriecin and camptothecin on DNA repair replication by mammalian cell extracts. Carcinogenesis, 13, 1371-1377.
6. Chen,M. and Beck,W.T. (1993) Teniposide-resistant CEM cells, which express mutant DNA topoisomerase II alpha, when treated with non-complex-stabilizing inhibitors of the enzyme, display no cross-resistance and reveal aberrant functions of the mutant enzyme. Cancer Res., 53, 5946-5953.
7. Roberge,M., Tudan,C., Hung,S.M., Harder,K.W., Jirik,F.R. and Anderson,H. (1994) Antitumor drug fostriecin inhibits the mitotic entry checkpoint and protein phosphatases 1 and 2A. Cancer Res., 54, 6115-6121.
8. Eriksson,J.E., Brautigan,D.L., Vallee,R., Olmsted,J., Fujiki,H. and Goldman,R.D. (1992) Cytoskeletal integrity in interphase cells requires protein phosphatase activity. Proc. Natl Acad. Sci. USA, 89, 11093-11097.
9. Lee,W.C., Yu,J.S., Yang,S.D. and Lai,Y.K. (1992) Reversible hyperphosphorylation and reorganization of vimentin intermediate filaments by okadaic acid in 9L rat brain tumor cells. J. Cell. Biochem., 49, 378-393.
10. Chartier,L., Rankin,L.L., Allen,R.E., Kato,Y., Fusetani,N., Karaki,H., Watabe,S. and Hartshome,D.J. (1991) Calyculin-A increases the level of protein phosphorylation and changes the shape of 3T3 fibroblasts. Cell Motil. Cytoskel., 18, 26-40.
11. Hirano,K. and Harishorne,D.J. (1993) Phosphorylation of vimentin in the C-terminal domain after exposure to calyculin-A. Eur. J. Cell Biol., 62, 59-65.
12. cdc2 kinase activity and histone H1 hyperphosphorylation, but is associated with enhanced histone H2A and H3 phosphorylation. EMBO J., 14, 976-985.
13. Laemmli,U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
14. Steinert,P., Zackroff,R., Aynardi-Whitman,M. and Goldman,R.D. (1982) Isolation and characterization of intermediate filaments. Methods Cell Biol., 24, 399-419.
15. Chou,Y.H., Rosevear,E. and Goldman,R.D. (1989) Phosphorylation and disassembly of intermediate filaments in mitotic cells, Proc. Natl Acad. Sci. USA. 86, 1885-1889.
16. Boyle,W.J., van DerGeer,P. and Hunter,T. (1991) Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol., 201, 110-149.
17. Cohen,P., Holmes,C.F.B. and Tsukitani,Y. (1990) Okadaic acid: a new probe for the study of cellular regulation. Trends Biochem. Sci., 15, 98-102.
18. Th'ng,J.P.H., Wright,P.S., Hamaguchi,J., Lee,M.G., Norbury,C.J., Nurse,P. and Bradbury,E.M. (1990) The FT210 cell line is a mouse G2 phase mutant with a temperature-sensitve CDC2 gene product. Cell, 63, 313-324.
19. Inagaki,M., Nishi,Y., Nishizawa,K., Masuyama,M. and Sata,C. (1987) Site-specific phosphorylation induces disassembly of vimentin filaments in vitro. Nature, 328, 649-652.
20. Ando,S., Tanabe,K., Gonda,Y., Sato,C. and Inagaki,M. (1989) Domain- and sequence-specific phosphorylation of vimentin induces disassembly of the filament structure. Biochemistry, 28, 2974-2979.
21. Geisler,N., Hatzfeld,M. and Weber,K. (1989) Phosphorylation in vitro of vimentin by protein kinases A and C is restricted to the head domain. Identification of the phosphoserine sites and their influence on filament formation. Eur. J. Biochem., 183, 441-447.
22. Fuchs,E. and Weber,K. (1994) Intermediate filaments: structure, dynamics, function and disease. Annu. Rev. Biochem., 63, 345-382.
23. cdc2 phosphorylation of vimentin. Cell, 62, 1063-1071.
24. cdc2 phosphorylates vimentin at a unique N-terminal site. J. Biol. Chem., 266, 7325-7328.
25. de Jong,S., Zijlstra,J.G., Mulder,N.H. and de Vries,E.G.E. (1991) Lack of cross-resistance to fostriecin in a human small-cell lung carcinoma cell line showing topoisomerase II-related drug resistance. Cancer Chemother. Pharmacol., 28, 461-464.
26. Geisler,N. and Weber,K. (1988) Phosphorylation of desmin in vitro inhibits formation of intermediate filaments: identification of three kinase A sites in the aminoterminal head domain. EMBO J., 7, 15-20.
27. Inagaki,M., Gonda,Y., Matsuyama,M., Nishizawa,K., Nishi,Y. and Sato,C. (1988) Intermediate filament reconstitution in vitro. The role of phosphorylation on the assembly-dissembly of desmin. J. Biol. Chem., 263, 5970-5978.
28. MacMillan-Crow,L.A. and Lincoln,T.M. (1994) High-affinity binding and localization of the cyclic GMP-dependent protein kinase with the intermediate filament protein vimentin. Biochemistry, 3318, 8035-8043.
29. Pryzwansky,K.B., Wyatt,T.A. and Lincoln,T.M. (1995) Cyclic guanosine monophosphate-dependent protein kinase is targeted to intermediate filaments in A23187-stimulated human neutrophils. Blood, 8524, 222-230.
30. Murti,K.G., Kaur,K. and Goorha,R.M. (1992) Protein kinase C associates with intermediate filaments and stress fibers. Exp. Cell Res., 202, 36-44.
31. Haystead,T.A., Carling,D., Tsukitani,Y., Cohen,P. and Hardie,D.G. (1989) Effects of the tumour promoter okadaic acid on intracellular protein phosphorylation and metabolism. Nature. 337, 78-81.
32. Weinstein,I.B. (1991) Nonmutagenic mechanisms in carcinogenesis: role of protein kinase C in signal transduction and growth control. Environ. Health Perspect., 93, 175-179.
33. Fujiki,H., Suganuma,M., Yoshizawa,S., Nishiwaki,S., Winyar,B. and Sugimura,T. (1991) Mechanisms of action of okadaic acid class tumor promoters on mouse skin. Environ. Health Perspect., 93, 211-214.
34. Nishizuka,Y. (1984) The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature, 308, 693-698.
35. 2- and phorbol esters. Nature. 317, 546-549.
36. Bertrand,F., Veissiere,D., Hermelin,B., Paul,A., Capeau,J., Picard,J. and Cherqui,G. (1994) Phosphorylation of vimentin is an intermediate step in protein kinase C-mediated glycoconjugate secretion. Am. J. Physiol., 266, C611-C621.